Ladenburg Thalmann Financial Services’s Rigel Pharmaceuticals RIGL Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$12K	Hold	583	–	–	﹤0.01%	4409
2019 Q3	$11K	Hold	583	–	–	﹤0.01%	4360
2019 Q2	$15K	Hold	583	–	–	﹤0.01%	4235
2019 Q1	$15K	Buy	583 +442	+313%	+$10.1K	﹤0.01%	4178
2018 Q4	$3K	Hold	141	–	–	﹤0.01%	4793
2018 Q3	$5K	Hold	141	–	–	﹤0.01%	4610
2018 Q2	$5K	Hold	141	–	–	﹤0.01%	4601
2018 Q1	$5K	Buy	+141	New	+$5.64K	﹤0.01%	4601

Other funds holding RIGL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ladenburg Thalmann Financial Services's RIGL Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Rigel Pharmaceuticals (RIGL) position steady in Q4 2019 at 583 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #4409.

Ladenburg Thalmann Financial Services first reported a position in RIGL in Q1 2018 and has held it in 8 quarters since. The position peaked at $15K in Q2 2019. 136 funds tracked by Wall St. Rank hold RIGL as of Q4 2019.

Ladenburg Thalmann Financial Services held 583 shares of Rigel Pharmaceuticals worth $12K as of Q4 2019.
Ladenburg Thalmann Financial Services left its Rigel Pharmaceuticals share count unchanged in Q4 2019.
Rigel Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4409 holding.
Ladenburg Thalmann Financial Services first reported a position in Rigel Pharmaceuticals in Q1 2018 and has held it in 8 quarters since.
Ladenburg Thalmann Financial Services's Rigel Pharmaceuticals position peaked at $15K in Q2 2019.
136 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.